← All organizations

Angiocrine Bioscience

For profitWebsite ↗

Also known as: Angiocrine Bioscience | Angiocrine Bioscience, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 30, 2024

Timeline

2010s

Jun 1, 2012
Angiocrine Bioscience— Founded

Drugs by trial phase (5 distinct, 5 trials)

Phase 3 (1 own, 0 via acquisition)

ab-205

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

NCT06456073CollaboratorPhase 1Sep 30, 2024
NCT05181540Lead sponsorPhase 3Feb 21, 2022
NCT05181540Study directorPhase 3Feb 21, 2022
NCT04190862CollaboratorPhase 1Dec 5, 2019
NCT03925935Study directorPhase 1May 7, 2019
NCT03925935Lead sponsorPhase 1May 7, 2019
NCT03483324Study directorPhase 1Apr 24, 2018
NCT03483324Lead sponsorPhase 1Apr 24, 2018

Details

Founded: New York, NY, US Jun 1, 2012
Last known activity: Sep 30, 2024